EEV
Live / Allowed — Fourth extension granted (statement of use) (as of 28 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Dec 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98308474
- Mark type
- Word mark
- Filed
- 11 Dec 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for human use, namely, pharmaceuticals for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
Prosecution history
- 29 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Sept 2026 — SOU EXTENSION 4 GRANTED
- 28 Sept 2026 — SOU EXTENSION 4 FILED
- 28 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 3 GRANTED
- 04 Mar 2026 — SOU EXTENSION 3 FILED
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2025 — SOU EXTENSION 2 GRANTED
- 20 Aug 2025 — SOU EXTENSION 2 FILED
- 20 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2025 — SOU EXTENSION 1 GRANTED
- 04 Mar 2025 — SOU EXTENSION 1 FILED